Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_assertion type Assertion NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_head.
- NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_assertion description "[Employing EGFR inhibition with erlotinib specifically at this premalignant stage was effective in decreasing the incidence of ER-negative breast tumors in this mouse model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_provenance.
- NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_assertion evidence source_evidence_literature NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_provenance.
- NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_assertion SIO_000772 21396117 NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_provenance.
- NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_assertion wasDerivedFrom befree-20140225 NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_provenance.
- NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_assertion wasGeneratedBy ECO_0000203 NP900274.RARzhsUFTI9Qu-QTmMnmsvVv7CXmbx8WqBO5y4_PpmEIg130_provenance.